Skip to main content

Medical Tourism Going Pro




There was a time in India when Air travel, matrimony, Jobs and Real estate were not organised, and then came Yatra.com, Bharatmatrimony.com, Naukri.com and magicbricks.com to organise it..Result= Major Hit



If we have a look at the medical tourism side of Online Reach and approach, We have everything A rich heritage, toursit attractions, High tech specialists, Good hospitals..everything...






Then why even good sites like recoverdiscover.com are not getting enough traffic, The website though older than Blog are not able to get good rankings. While the Government has been most positively speaking about promoting medical tourism, it seems that when opportunity comes calling, it is looking the other way.










Read this:



Government stance
"We have not come to that stage of taking that leap in medical tourism yet," said B. Suman, Tourism Director, for not participating in the expo. "Hospitals here have not come up as expected," Mr. Suman said. "However, a meeting will be held in the end of April and the Government will be planning some promotion in West Asia and Europe," he added.









Why are we failing?



Concept failed to ‘mature’ due to lack of synergy between Tourism Department and hospitals
Insurance companies prefer sending patients only to JCI certified hospitals.



A decade back, when medical tourism was introduced in twin cities, it was touted as the next big sector, with a potential to match the growth of information technology and biotechnology.
Ironically, IT and biotech have forged ahead, while medical tourism is still struggling to emerge out of its embryonic state.
Presently, flow of foreign patients can be at best described as ‘modest’. In a day, only about 15 to 20 patients from Bangladesh, Middle East, Sri Lanka, are admitted at Apollo, Care and L.V. Prasad Eye Institute. Given the presence of best doctors, when compared globally, this is modest.






Why do people travel abroad for Treatments?



People are trying to find better deals abroad. Health care is expensive in the UK; not in monetary terms, but due to a high time cost from long waiting lists. Health care is expensive in the U.S.; not due to time costs from waiting lists, but from high monetary cost.






“More than 70,000 Britons will have treatment abroad this year – a figure that is forecast to rise to almost 200,000 by the end of the decade.” Many of these individuals are seeking treatment in countries such as India, Hungary, Turkey, Germany, Malaysia, Poland and Spain.






Why health care is much cheaper in the above stated countries?



Health care systems suffer from Baumol’s cost disease: it’s a labor-intensive service that doesn’t offer huge scope for gains in labor productivity. The number of hours it takes to manufacture a car is consistently falling, but the number of hours it takes to perform doctor’s visits is roughly the same as it has always been. As a society gets richer, in order to attract workers, the labor intensive service has to pay competitive wages with the sectors where productivity is rising rapidly; that means that costs for labor-intensive services rise faster than the general price level.






What is the Success Key?



88% of the people that begin research on medical tourism actually fail to carry-out their intentions. This is attributed to an incomplete understanding about the medical travel experience.Remember the three key words...TTT, III i.e.



Trust-----------------> TPA----------------------->Transaction



Information-------------> IDEA---------------->Induction



Read this story of a Medical Tourism Seeker and this will surely help you understand the Psyche of a Tourist...












will come up with more.....
























Comments

Popular posts from this blog

Artificial Intelligence Policy and Governance in HEALTHCARE

  Artificial Intelligence has become the new frontier for digital transformation. Several  #digitalhealth  businesses of today rely on Machine Learning,  #AI  and other such technologies to make healthcare delivery more efficient and comprehensive. However, the efficient and responsible use of AI tools is an ongoing discussion and would mean culture, data management, technology shifts in the industry, and required up-grading and training professionals for better coordination. Hence, with the growing market potential and interest in AI, it is imperative to develop a thoughtthrough regulatory and legal framework on the adoption and use of AI. I have set forward a hypotheses to design a policy framework for AI technologies in my paper- "𝐀𝐫𝐭𝐢𝐟𝐢𝐜𝐢𝐚𝐥 𝐈𝐧𝐭𝐞𝐥𝐥𝐢𝐠𝐞𝐧𝐜𝐞 𝐢𝐧 𝐇𝐞𝐚𝐥𝐭𝐡 𝐏𝐨𝐥𝐢𝐜𝐲 – 𝐀 𝐆𝐥𝐨𝐛𝐚𝐥 𝐏𝐞𝐫𝐬𝐩𝐞𝐜𝐭𝐢𝐯𝐞" last year https://lnkd.in/emi3XWwa cited further by "𝐓𝐡𝐞 𝐐𝐮𝐚𝐧𝐝𝐚𝐫𝐲 𝐢𝐧 𝐃𝐚𝐭𝐚 𝐏𝐫𝐨𝐭𝐞𝐜𝐭𝐢𝐨𝐧 𝐚𝐧𝐝 𝐑

Artificial intelligence and Technology for Dentistry

Have you heard of this company  ORCA Dental AI ? ORCA combines clinical expertise with machine learning and AI technologies to create diagnostic reports, treatment plan suggestions and smart clinical predictions. Good to learn about these innovations that benefit every stakeholder in the value chain. Recently,  VideaHealth  raised $20M to Expand AI-Based Diagnostics led by Spark Capital including existing investors Zetta Venture Partners. Among its many benefits to dentists and patients are: – A 31% increase in diagnosis rate for cavities and 26% increase in treatment plan value; – An increase in case acceptance by patients due to second opinions; – Automated workflows accelerate treatment planning and charting; Another company touting AI-powered dental care and practice management is  Overjet , which announced a $42.5 million Series B funding round in December months after it had scored $27 million in Series A funding.  Pearl  provides AI for dental images to assist in diagnosis. It l

Big Data Analytics- The Microscope and Telescope for Pharma/CRO

This article is produced in consultation with Industry experts, and KOLs in India and across the world and especially highlights how “Predictive Analytics algorithms” are poised to provide Useful Analytics to the Pharma industry.   In today’s highly competitive market, it is extremely important for contract research and manufacturers to have access to information that allows them to target the specific segments of the pharmaceutical and biotechnology industry that are looking to outsource the particular services they provide.  Understanding shifts in annual outsourcing budgets and spending can help CROs and CMOs to better position themselves for capturing business, particularly at a time when many – if not all – pharma and biotech companies are looking to cut costs and streamline operations.  As per a recent report by NiceInsights, Analytical Services, Clinical Research, and Clinical Monitoring will be the most demanded services over the next 12 to 18 months. For CROs and CMOs looki